Genetic and epigenetic changes in the common Ip36 deletion in neuroblastoma tumours

被引:44
作者
Caren, H.
Fransson, S.
Ejeskar, K.
Kogner, P.
Martinsson, T. [1 ]
机构
[1] Gothenburg Univ, Sahlgrens Univ Hosp, Inst Biomed, Dept Clin Genet, S-41345 Gothenburg, Sweden
[2] Karolinska Hosp & Inst, Dept Woman & Child Hlth, Childhood Canc Res Unit, S-17176 Stockholm, Sweden
关键词
neuroblastoma; Ip; mutation; epigenetics; PIK3CD;
D O I
10.1038/sj.bjc.6604032
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Chromosome 1p is frequently deleted in neuroblastoma (NB) tumours. The commonly deleted region has been narrowed down by loss of heterozygosity studies undertaken by different groups. Based on earlier mapping data, we have focused on a region on 1p36 (chr1: 7 765 595-11 019 814) and performed an analysis of 30 genes by exploring features such as epigenetic regulation, that is DNA methylation and histone deacetylation, mutations at the DNA level and mRNA expression. Treatment of NB cell lines with the histone deacetylase inhibitor trichostatin A led to increased gene transcription of four of the 30 genes, ERRFII (MIG-6), PIK3CD, RBP7 (CRBPIV) and CASZ1, indicating that these genes could be affected by epigenetic downregulation in NBs. Two patients with nonsynonymous mutations in the PIK3CD gene were detected. One patient harboured three variations in the same exon, and p.R188W. The other patient had the variation p.M655I. In addition, synonymous variations and one variation in an intronic sequence were also found. The mRNA expression of this gene is downregulated in unfavourable, compared to favourable, NBs. One nonsynonymous mutation was also identified in the ERRFII gene, p.N343S, and one synonymous. None of the variations above were found in healthy control individuals. In conclusion, of the 30 genes analysed, the PIK3CD gene stands out as one of the most interesting for further studies of NB development and progression.
引用
收藏
页码:1416 / 1424
页数:9
相关论文
共 44 条
  • [1] Imbalance of the mitochondrial pro- and anti-apoptotic mediators in neuroblastoma tumours with unfavourable biology
    Abel, F
    Sjöberg, RM
    Nilsson, S
    Kogner, P
    Martinsson, T
    [J]. EUROPEAN JOURNAL OF CANCER, 2005, 41 (04) : 635 - 646
  • [2] Abel F, 2004, INT J ONCOL, V25, P1297
  • [3] Analyses of apoptotic regulators CASP9 and DFFA at 1p36.2, reveal rare allele variants in human neuroblastoma tumours
    Abel, F
    Sjöberg, RM
    Ejeskär, K
    Krona, C
    Martinsson, T
    [J]. BRITISH JOURNAL OF CANCER, 2002, 86 (04) : 596 - 604
  • [4] Tissue-wide expression profiling using cDNA subtraction and microarrays to identify tumor-specific genes
    Amatschek, S
    Koenig, U
    Auer, H
    Steinlein, P
    Pacher, M
    Gruenfelder, A
    Dekan, G
    Vogl, S
    Kubista, E
    Heider, KH
    Stratowa, C
    Schreiber, M
    Sommergruber, W
    [J]. CANCER RESEARCH, 2004, 64 (03) : 844 - 856
  • [5] Smallest region of overlapping deletion in I p36 in human neuroblastoma: A I Mbp cosmid and PAC contig
    Bauer, A
    Savelyeva, L
    Claas, A
    Praml, C
    Berthold, F
    Schwab, M
    [J]. GENES CHROMOSOMES & CANCER, 2001, 31 (03) : 228 - 239
  • [6] Benn DE, 2000, CANCER RES, V60, P7048
  • [7] Bridge JA, 2000, GENE CHROMOSOME CANC, V27, P337, DOI 10.1002/(SICI)1098-2264(200004)27:4<337::AID-GCC1>3.0.CO
  • [8] 2-1
  • [9] A cluster of genes located in Ip36 are down-regulated in neuroblastomas with poor prognosis, but not due to CpG island methylation
    Caren, Helena
    Ejeskar, Katarina
    Fransson, Susanne
    Hesson, Luke
    Latif, Farida
    Sjoberg, Rose-Marie
    Krona, Cecilia
    Martinsson, Tommy
    [J]. MOLECULAR CANCER, 2005, 4 (1)
  • [10] Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma
    Caron, H
    vanSluis, P
    deKraker, J
    Bokkerink, J
    Egeler, M
    Laureys, G
    Slater, R
    Westerveld, A
    Voute, PA
    Versteeg, R
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (04) : 225 - 230